Podcast: Download (Duration: 1:00 — 1.4MB)
Subscribe: RSS
So-called ‘bispecific antibodies,’ are racking up some impressive results when it comes to treating certain cancers, recent studies show. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins says making individualized antibodies for cancer treatment as well as …
The blood cancer multiple myeloma largely responds to a specially constructed antibody known as a BITE, for bispecific T cell engager, a recent study shows. Kimmel Cancer Center director William Nelson at Johns Hopkins describes the data. Nelson: In this …
Just how good is a specialized antibody for multiple myeloma? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Antibodies are usually part of our immune response to infections, but now are being constructed in the laboratory to fight cancer, with a recent study demonstrating just how effective they can be against a type of blood cancer. William Nelson, …
Can a unique antibody curb cancer? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
If you have recently been diagnosed with cancer, your best bet for treatment may include enrolling in a clinical trial, where new treatments are being assessed, usually by comparing them with standard treatment. Yet a new study finds that under …
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
A very low percentage of people who receive Medicare benefits in the US and have cancer enroll in clinical trials, a new study finds. Johns Hopkins Kimmel Cancer Center director William Nelson reviews the data. Nelson: If you look at …
Why don’t more people with cancer enroll in clinical trials? Elizabeth Tracey reports Read more »
Research and development have very much improved treatments for many cancers, and that’s reflected in the nation’s latest report on cancer. Johns Hopkins Kimmel Cancer Center director William Nelson says these improvements are especially seen in lung cancer and the …
